The working documents received from the PDG or one or more pharmacopoeial sources ( USP , Ph . Eur . , or JP ) tha contain the proposed pharmacopoeial text and any other suppor documents provided for Q4B evaluation .Using any of the interchangeable methods , an analyst will reach the same accept or reject decisions irrespective of which PDG pharmacopeia is used .Information concerning how the evaluated pharmacopoeial text can be used .
……